Literature DB >> 18030364

Enhanced expression of interferon-gamma-induced antigen-processing machinery components in a spontaneously occurring cancer.

Fulvia Cerruti1, Marina Martano, Claudio Petterino, Enrico Bollo, Emanuela Morello, Renato Bruno, Paolo Buracco, Paolo Cascio.   

Abstract

In human tumors, changes in the surface expression and/or function of major histocompatibility complex (MHC) class I antigens are frequently found and may provide malignant cells with a mechanism to escape control of the immune system. This altered human lymphocyte antigen (HLA) class I phenotype can be caused by either structural alterations or dysregulation of genes encoding subunits of HLA class I antigens and/or components of the MHC class I antigen-processing machinery (APM). Herein we analyze the expression of several proteins involved in the generation of MHC class I epitopes in feline injection site sarcoma, a spontaneously occurring tumor in cats that is an informative model for the study of tumor biology in other species, including humans. Eighteen surgically removed primary fibrosarcoma lesions were analyzed, and an enhanced expression of two catalytic subunits of immunoproteasomes, PA28 and leucine aminopeptidase, was found in tumors compared to matched normal tissues. As a functional counterpart of these changes in protein levels, proteasomal activities were increased in tissue extracts from fibrosarcomas. Taken together, these results suggest that alterations in the APM system may account for reduced processing of selected tumor antigens and may potentially provide neoplastic fibroblasts with a mechanism for escape from T-cell recognition and destruction.

Entities:  

Keywords:  MHC class I epitopes; PA28; Proteasome; antigen processing; immunoproteasome

Mesh:

Substances:

Year:  2007        PMID: 18030364      PMCID: PMC2077887          DOI: 10.1593/neo.07649

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  46 in total

1.  Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides.

Authors:  X Y Mo; P Cascio; K Lemerise; A L Goldberg; K Rock
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

2.  Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation.

Authors:  A Macagno; M Gilliet; F Sallusto; A Lanzavecchia; F O Nestle; M Groettrup
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

Review 3.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Authors:  F M Marincola; E M Jaffee; D J Hicklin; S Ferrone
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

4.  Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

Authors:  S Morel; F Lévy; O Burlet-Schiltz; F Brasseur; M Probst-Kepper; A L Peitrequin; B Monsarrat; R Van Velthoven; J C Cerottini; T Boon; J E Gairin; B J Van den Eynde
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

Review 5.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

6.  Coordinate downregulation of multiple MHC class I antigen processing genes in chemical-induced murine tumor cell lines of distinct origin.

Authors:  B Seliger; U Wollscheid; F Momburg; T Blankenstein; C Huber
Journal:  Tissue Antigens       Date:  2000-10

7.  How much longer will tumour cells fool the immune system?

Authors:  S Ferrone; J F Finerty; E M Jaffee; G J Nabel
Journal:  Immunol Today       Date:  2000-02

Review 8.  The potential role of inflammation in the development of postvaccinal sarcomas in cats.

Authors:  D W Macy; M J Hendrick
Journal:  Vet Clin North Am Small Anim Pract       Date:  1996-01       Impact factor: 2.093

Review 9.  Spontaneously occurring tumors of companion animals as models for human cancer.

Authors:  D M Vail; E G MacEwen
Journal:  Cancer Invest       Date:  2000       Impact factor: 2.176

Review 10.  Antigen-processing machinery breakdown and tumor growth.

Authors:  B Seliger; M J Maeurer; S Ferrone
Journal:  Immunol Today       Date:  2000-09
View more
  7 in total

1.  PA28γ-20S proteasome is a proteolytic complex committed to degrade unfolded proteins.

Authors:  Jean-Yves Alejandro Frayssinhes; Fulvia Cerruti; Justine Laulin; Angela Cattaneo; Angela Bachi; Sebastien Apcher; Olivier Coux; Paolo Cascio
Journal:  Cell Mol Life Sci       Date:  2021-12-16       Impact factor: 9.261

2.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

3.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

4.  Increased expression of PSME2 is associated with clear cell renal cell carcinoma invasion by regulating BNIP3‑mediated autophagy.

Authors:  Xiaoyun Wang; Fengbo Wu; Yutong Deng; Jinlong Chai; Yuehua Zhang; Gu He; Xiang Li
Journal:  Int J Oncol       Date:  2021-11-15       Impact factor: 5.650

Review 5.  PA28αβ: the enigmatic magic ring of the proteasome?

Authors:  Paolo Cascio
Journal:  Biomolecules       Date:  2014-06-19

6.  Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3.

Authors:  Mathilde Boulpicante; Romain Darrigrand; Alison Pierson; Valérie Salgues; Marine Rouillon; Benoit Gaudineau; Mehdi Khaled; Angela Cattaneo; Angela Bachi; Paolo Cascio; Sébastien Apcher
Journal:  Oncoimmunology       Date:  2020-05-21       Impact factor: 8.110

7.  Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies.

Authors:  Jessica Bordini; Federica Morisi; Fulvia Cerruti; Paolo Cascio; Clara Camaschella; Paolo Ghia; Alessandro Campanella
Journal:  Cancers (Basel)       Date:  2020-04-14       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.